» Articles » PMID: 29685587

The Pathophysiology of Myocardial Infarction-induced Heart Failure

Overview
Journal Pathophysiology
Publisher MDPI
Specialty Pathology
Date 2018 Apr 25
PMID 29685587
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF) is a multifactorial disorder and is usually the end stage of many cardiovascular diseases (CVD). HF presents one of the highest morbidity and mortality indices worldwide and high costs to public health organizations. Myocardial infarction (MI) is the most prevalent CVD in the Western world and leads to HF when its management is inadequate. It has a destructive potential for heart cells and abruptly reduces the cardiac output, a clinical condition known as heart dysfunction that might progress to HF. Many acute and chronic adaptations occur due to MI that progress to HF, e.g., neurohumoral hyperactivity, inflammatory response and cardiac remodeling. Herein, we reviewed in simplistic manner the processes involved in setting of MI until the establishment of HF.

Citing Articles

[Colchicine-Phoenix from the ashes].

Lunzer R, Delle-Karth G, Zeitlinger M, Prager M, Pracher L Wien Klin Wochenschr. 2025; 137(Suppl 1):1-33.

PMID: 39912853 PMC: 11802715. DOI: 10.1007/s00508-024-02490-7.


Comparison of diaphragmatic breathing exercises and incentive spirometry on the functional status of heart failure patients: a randomized controlled trial.

Nasirmoghadas A, Monjazebi F, Nasiri M, Feyzi A, Borhani F BMC Cardiovasc Disord. 2025; 25(1):17.

PMID: 39794689 PMC: 11724584. DOI: 10.1186/s12872-024-04464-z.


Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R Int J Mol Sci. 2024; 25(21).

PMID: 39519298 PMC: 11546116. DOI: 10.3390/ijms252111747.


Impact of Wearable Technology on Heart Failure Management.

Jafari N, Yousefi Ghalati S, Shahabi Raberi V, Moalemi S, Amin A Galen Med J. 2024; 13:e3469.

PMID: 39483862 PMC: 11525106. DOI: 10.31661/gmj.v13i.3469.


Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges.

Seow K, Ling A Ann Transl Med. 2024; 12(4):73.

PMID: 39118948 PMC: 11304428. DOI: 10.21037/atm-23-1936.